Our technology allows us to make cost-effective RNA

Our high-quality, low-cost RNA

We can make multiple forms of RNA at scale using a differentiated manufacturing platform. We believe our expertise and proprietary technology will allow us to bring RNA products quickly and cost-effectively to market.

Alternative RNA production methods are generally slow to develop and more expensive:

  • Cell-based fermentation does not achieve the cost needed for broadacre coverage in agriculture applications.
  • Conventional cell-free processes, such as in vitro transcription (IVT), are cost prohibitive for agricultural applications and require complex specialty input supply chains.

GreenLight has solved challenges to manufacturing at scale with:

  • Proprietary cell-free methodology that enables delivery of high volumes and less than $1/gram for the production of Technical Grade Active Ingredient (TGAI) dsRNA
  • Scalable and flexible architecture that accommodates manufacturing for a wide variety of applications

Put together, we believe our technologies and methods allow us to make scalable, cost-effective RNA.

Read more about our RNA manufacturing process

Carole Cobb, GreenLight Bio’s Former COO, shares some of the processing lessons from our manufacturing plant in Rochester, NY,  where the company is making dsRNA for agricultural uses.